Nom du produit:4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline
IUPAC Name:3-methyl-4-{[1,2,4]triazolo[1,5-a]pyridin-7-yloxy}aniline
- CAS:937263-71-3
- Formule moléculaire:C13H12N4O
- Pureté:95%+
- Numéro de catalogue:CM322205
- Poids moléculaire:240.27
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:937263-71-3
- Formule moléculaire:C13H12N4O
- Point de fusion:-
- Code SMILES:NC1=CC=C(OC2=CC3=NC=NN3C=C2)C(C)=C1
- Densité:
- Numéro de catalogue:CM322205
- Poids moléculaire:240.27
- Point d'ébullition:
- N° Mdl:MFCD28977540
- Stockage:Keep in a tight container and store at ambient temperature
Column Infos
- Tucatinib
- In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.